Literature DB >> 2691962

Plasmodium falciparum growth inhibition by human platelets in vitro.

F Peyron1, B Polack, D Lamotte, L Kolodie, P Ambroise-Thomas.   

Abstract

Platelets take an active part in immunological processes as well as in haemostasis, especially in the host-parasite relationship. Our aim is to assess the growth of Plasmodium falciparum, cultured in human erythrocytes in the presence of fresh washed human platelets, since thrombocytopaenia is frequently observed during malarial infections. Our results show that platelets induce a dose-related growth inhibition of P. falciparum. Both proliferation and maturation of intraerythrocytic stages of the parasite are inhibited. This growth inhibition is triggered by the parasite itself as neither specific antibodies nor any other components are needed to activate platelets. Activated platelets are directly toxic since complement is not involved. Furthermore, inhibition is not mediated by erythrocyte lysis or by toxic oxygen metabolites. Platelets induce an inhibition of P. falciparum growth, at least in vitro, although the importance of their role played in vivo in malarial immunity has yet to be evaluated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2691962     DOI: 10.1017/s0031182000059011

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  22 in total

1.  Adherence of platelets to Candida species in vivo.

Authors:  R Robert; S Nail; A Marot-Leblond; J Cottin; M Miegeville; S Quenouillere; C Mahaza; J M Senet
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 3.  Role of platelet adhesion in homeostasis and immunopathology.

Authors:  D N Männel; G E Grau
Journal:  Mol Pathol       Date:  1997-08

Review 4.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

5.  Platelets activate a pathogenic response to blood-stage Plasmodium infection but not a protective immune response.

Authors:  Irene Gramaglia; Joyce Velez; Valery Combes; Georges E R Grau; Melanie Wree; Henri C van der Heyde
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

6.  Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils.

Authors:  L Christin; D R Wysong; T Meshulam; R Hastey; E R Simons; R D Diamond
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

7.  Human platelet inhibition of Toxoplasma gondii growth.

Authors:  B F Chumpitazi; J Simon; B Polack; F Peyron; S Picot; J Ricard; P Ambroise-Thomas
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

8.  Platelet α-granules contribute to organ-specific pathologies in a mouse model of severe malaria.

Authors:  Thayer K Darling; Michael P Schenk; Chengjing C Zhou; Franklin M Maloba; Patrice N Mimche; Jonathan M Gibbins; Shawn M Jobe; Tracey J Lamb
Journal:  Blood Adv       Date:  2020-01-14

9.  Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is associated with high parasitemia but not severe clinical manifestations of malaria in African children.

Authors:  Mònica Arman; Ahmed Raza; Louisa J Tempest; Kirsten E Lyke; Mahamadou A Thera; Abdoulaye Koné; Christopher V Plowe; Ogobara K Doumbo; J Alexandra Rowe
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

10.  Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood.

Authors:  Kanlaya Sriprawat; Supaporn Kaewpongsri; Rossarin Suwanarusk; Mara L Leimanis; Usa Lek-Uthai; Aung Pyae Phyo; Georges Snounou; Bruce Russell; Laurent Renia; François Nosten
Journal:  Malar J       Date:  2009-06-02       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.